Cointime

Verastem Oncology

company

About

Verastem is a biopharmaceutical company that focuses on discovering and developing novel drugs that selectively target cancer stem cells.

  • 101 - 250

Highlights

Total Funding Amount
$25M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$25M
Industries
Biopharma,Biotechnology,Pharmaceutical
Founded date
Jan 1, 2010
Number Of Employee
101 - 250
Operating Status
Active

Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of medicines to improve the lives of patients diagnosed with cancer. Its portfolio consists of small molecule kinase inhibitors that inhibit critical signaling pathways, which promote cancer cell survival and tumor growth.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$25M
Verastem Oncology has raised a total of $25M in funding over 2 rounds. Their latest funding was raised on Mar 23, 2017 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 23, 2017 Post-IPO Debt $25M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
Verastem Oncology is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital — Post-IPO Debt
Cointime
เนื้อหา
บริษัท